Biomarker Technologies Market 2028 By Product, Technology, Indication, Application, and Geography | The Insight Partners

report image

Biomarker Technologies Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Instruments, Assay and Reagents, and Consumables); Technology (Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), Immunoassay, and Others); Indication (Cancer, Infectious Diseases, Autoimmune Disorders, Cardiovascular Disorders, and Others); Application (Drug Discovery, Diagnostics, and Personalized Medicine), and Geography

Report Code: TIPRE00003070 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming


A biomarker is a biological trait that is examined and assessed as a predictor of normal biological or pathological processes, or a therapeutic response. Gene expression patterns, for example, are used to diagnose a variety of disorders. In a biological system, a biomarker is a measurable sign that is used to indicate exposure, susceptibility, effect, or clinical disease. This technology can be used in observational and analytic epidemiology, screening and diagnosis, randomized clinical trials, and prognosis, among other.


The "Global Biomarker Technologies Market Analysis to 2028" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of the biomarker technologies market with detailed market segmentation by product, technology, indication, application, and geography. The report provides key statistics on the market status of the leading biomarker technologies market players and offers key trends and opportunities in the market.


  •   Based on product, the market is bifurcated into instruments, assay and reagents, and consumables
  •   Based on technology, the market is bifurcated into polymerase chain reaction (PCR), next generation sequencing (NGS), immunoassay, and others
  •   Based on indication, the market is bifurcated into cancer, infectious diseases, autoimmune disorders, cardiovascular disorders, and others
  •   Based on application, the market is bifurcated into drug discovery, diagnostics, and personalized medicine



  •   Rising healthcare expenditure
  •   Growing number of Clinical Research Organization (CROs)
  •   Low cost of clinical trials in developing economies


  •   High capital investments and low cost-benefit ratio


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The biomarker technologies market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the biomarker technologies market in these regions.


COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.


The report covers key developments in the biomarker technologies market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from biomarker technologies market are anticipated to lucrative growth opportunities in the future with the rising demand for biomarker technologies in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the biomarker technologies market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   Illumina, Inc.
  •   Agilent Technologies, Inc.
  •   Shimadzu Corporation
  •   Thermo Fisher Scientific, Inc.
  •   F. Hoffmann-La Roche AG
  •   Bio-Rad Laboratories, Inc.
  •   QIAGEN
  •   Merck KGaA
  •   Waters Corporation
  •   Danaher Corporation

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
The List of Companies

1. Illumina, Inc.
2. Agilent Technologies, Inc.
3. Shimadzu Corporation
4. Thermo Fisher Scientific, Inc.
5. F. Hoffmann-La Roche AG
6. Bio-Rad Laboratories, Inc.
8. Merck KGaA
9. Waters Corporation
10. Danaher Corporation
11. PerkinElmer Inc.
12. LI-COR, Inc.
13. General Electric Company
14. BioMerieux SA
15. Biomarker Technologies
16. Myriad Genetics, Inc.
17. Sysmex Corporation
18. Quest Diagnostics Incorporated
19. Siemens
20. Abbott Laboratories
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount